Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials

BACKGROUND: The role of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) reducing risk of cardiovascular events (CVEs) and preserving kidney function in patients with chronic kidney disease is well-documented. However, the efficacy and safety of these agents...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Youxia, Ma, Xinxin, Zheng, Jie, Jia, Junya, Yan, Tiekun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493067/
https://www.ncbi.nlm.nih.gov/pubmed/28666408
http://dx.doi.org/10.1186/s12882-017-0605-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493067/
https://www.ncbi.nlm.nih.gov/pubmed/28666408
http://dx.doi.org/10.1186/s12882-017-0605-7

Ejemplares similares